Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
29 hedge funds and large institutions have $84.2M invested in Global Cord Blood Corporation in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 6 closing their positions.
159% more capital invested
Capital invested by funds: $32.5M → $84.2M (+$51.7M)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
3% less funds holding
Funds holding: 30 → 29 (-1)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
+$35.3M |
| 2 |
GP
GLG Partners
London,
United Kingdom
|
+$2.88M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$863K |
| 4 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$245K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$99.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$2.32M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$931K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$156K |
| 4 |
Renaissance Technologies
New York
|
-$138K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$126K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of Montreal
Toronto,
Ontario, Canada
| $5K | – | – | – |
|
27
Creative Planning
Overland Park,
Kansas
| $2K | – | – | – |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $1K | -$21.6K | -4,330 | -96% |
|
|
PAM
29
Panagora Asset Management
Boston,
Massachusetts
| – | -$931K | -182,288 | Closed |
|
|
30
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$156K | -30,628 | Closed |
|
|
31
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$126K | -24,562 | Closed |
|
|
SIM
32
Spark Investment Management
New York
| – | -$61K | -12,100 | Closed |
|
33
Two Sigma Advisers
New York
| – | -$53K | -10,400 | Closed |
|
34
Barclays
London,
United Kingdom
| – | -$18K | -3,440 | Closed |
|
CO Hedge Fund Activity: Q4 2016 in Review
29 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2016, worth a combined $84.2M — up 159% from $32.5M a quarter earlier.
Fund positioning in CO was balanced in Q4 2016: 6 funds opened new positions, 6 closed out, 6 added to existing stakes and 9 trimmed.
The largest buyer was Skandinaviska Enskilda Banken (SEB), opening a new position worth an estimated $35.3M. The largest seller was Citigroup, cutting an estimated $2.32M.
- 29 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2016, down from 30 in Q3 2016.
- Funds reported $84.2M of Global Cord Blood Corporation stock for Q4 2016, up 159% quarter-over-quarter.
- 6 funds opened new Global Cord Blood Corporation positions in Q4 2016 and 6 closed out, a net change of 0 holders.
- The largest Global Cord Blood Corporation buyer in Q4 2016 was Skandinaviska Enskilda Banken (SEB), an estimated $35.3M added.
- The largest Global Cord Blood Corporation seller in Q4 2016 was Citigroup, an estimated $2.32M sold.
Based on aggregated 13F filings for Q4 2016.